Volume 31, Issue 9 e13049
ORIGINAL ARTICLE

Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation

Lan Gao

Corresponding Author

Lan Gao

Deakin Health Economics, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Global Obesity Centre, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Correspondence

Lan Gao, Deakin Health Economics, Centre for Population Health Research, Deakin University, Geelong, Australia; Global Obesity Centre, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia.

Email: [email protected]

Search for more papers by this author
Marj Moodie

Marj Moodie

Deakin Health Economics, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Global Obesity Centre, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Search for more papers by this author
Victoria Brown

Victoria Brown

Deakin Health Economics, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Global Obesity Centre, Centre for Population Health Research, Deakin University, Geelong, VIC, Australia

Search for more papers by this author
Sharon Avery

Sharon Avery

Malignant Haematology and Stem Cell Transplantation Service, Alfred Health, Melbourne, VIC, Australia

Search for more papers by this author
First published: 05 July 2017
Citations: 4

Funding information

This study was supported by the Victorian Government.

ABSTRACT

To evaluate the cost-effectiveness of a lifestyle modification program targeting long-term survivors of hematological malignancy treated with hemopoietic stem cell transplantation, a multistate life table Markov model was used to calculate health outcomes for both the intervention and no intervention. Cost per health-adjusted life year (HALY) saved was reported for four scenarios: all participants with/without standard weight regain, and participants who at baseline were overweight with/without standard weight regain. The program recruited 53 participants and was associated with reductions in body weight of 2.2 kg and BMI 0.8 units on intervention completion (12 months) at a cost of $1233/participant. These adipose reductions were sustained and remained significant at 24 months. The incremental cost-effectiveness ratios varied from $118 418 per HALY to dominant, depending on the weight regain assumption. The program may be cost-effective in transplant survivors, with the results most sensitive to the weight regain assumption and intervention cost.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.